Skip to main
TCDAQ
TCDAQ logo

Tricida Inc (TCDAQ)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Tricida Inc (TCDAQ) Stock

About Tricida Inc (TCDAQ)

Tricida, Inc. is a pharmaceutical company, which engages in the development and commercialization of orally administered polymer drugs for chronic kidney diseases. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in Sacramento, CA.
Market cap$600
Today's volume
Revenue (TTM)
Avg. daily volume284.05K
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)-3.9x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 13, 2025, the market cap for TCDAQ stock is $600

The 52-week high for TCDAQ stock is $13.85. The current TCDAQ stock price $undefined is 100.00% below its 52-week high

No, the TCDAQ stock does not pay dividends to its shareholders

How to buy TCDAQ stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TCDAQ stock

    Navigate to the Explore page. Then, type TCDAQ into the search bar. When you see TCDAQ stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TCDAQ stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy Tricida Inc (TCDAQ) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.